Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus
- PMID: 15739976
Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus
Comment on
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.